Methoxsalen S.A.L.F.

Methoxsalen, the active ingredient in Methoxsalen S.A.L.F., is a psoralen presented as a pharmaceutical preparation for extracorporeal use. It is employed in the management of psoriasis, vitiligo, and cutaneous T‑cell lymphoma, where it acts as a photosensitizing agent to modulate abnormal skin cell proliferation.

GNH USA supplies Methoxsalen S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable global distribution. The company provides regulatory documentation and supports import logistics for qualified healthcare providers.

Methoxsalen is a psoralen used in phototherapy for several dermatologic conditions. - Psoriasis: reduces plaque formation and scaling by inhibiting keratinocyte proliferation. - Vitiligo: promotes repigmentation of depigmented skin areas through controlled UVA exposure. - Cutaneous T‑cell lymphoma: helps control skin lesions by inducing apoptosis of malignant T‑cells.

Methoxsalen may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Erythema: skin redness after UVA exposure. - Pruritus: itching of treated areas. Serious or Rare Side Effects: - Phototoxic burn: severe skin injury from excessive UVA. - Hemolysis: red blood cell breakdown, especially in G6PD deficiency. - Liver enzyme elevation: signs of hepatic stress. - Severe allergic reaction: anaphylaxis or angioedema.

When using methoxsalen, several precautions should be observed to minimize risks. - Patient selection: avoid use in individuals with porphyria or severe liver disease. - UVA exposure: limit exposure time and intensity according to protocol to prevent phototoxic injury. - G6PD deficiency: screen patients, as hemolysis risk is increased. - Concomitant photosensitizers: discontinue other photosensitizing drugs to reduce additive effects. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture and light.

Methoxsalen can interact with several medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Antifungal azoles (e.g., ketoconazole): increase methoxsalen plasma levels, raising toxicity risk. - Phenobarbital and other enzyme inducers: reduce methoxsalen effectiveness by accelerating metabolism. - Other photosensitizing agents (e.g., tetracyclines): amplify phototoxic reactions. Moderate Interactions (Monitor Closely): - Oral contraceptives: may experience reduced efficacy due to hepatic enzyme induction. - Warfarin: potential alteration of anticoagulant effect; monitor INR. - Retinoids (e.g., acitretin): increased skin irritation risk.